Cancer Research Annual Meeting 2010  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 1010-1015, May 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sell, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sell, S.

Radioimmunoassay of Rat {alpha}1-Fetoprotein1

Stewart Sell

Department of Pathology, University of California at San Diego Medical School, La Jolla, California 92037

A competitive binding radioimmunoassay for rat {alpha}1-fetoprotein ({alpha}1F) has been developed. This assay is approximately 20,000 times more sensitive than double diffusion in agar for {alpha}1F detection, the threshold being approximately 5 ng. Further purification of apparently pure (by immunodiffusion and immunization) radiolabeled {alpha}1F is required for the specific assay. An assay for a previously undetected contaminant(s) is used to check the purity of rat {alpha}1F isolated by isoelectric focusing in order to obtain the purified unlabeled {alpha}1F needed to establish the standard inhibition curve.

1 Supported by Grant CA-12473 and Contract E-72-3258 from the National Cancer Institute, NIH, Bethesda, Md.

Received 12/ 1/72. Accepted 1/26/73.




This article has been cited by other articles:


Home page
Toxicol PatholHome page
D. Sondergaard, F. Taylor, and P. M. Newberne
Effects of the Irreversible Ornithine Decarboxylase Inhibitor, {alpha}-Difluoromethylornithine, Aflatoxin B1, and Choline Deficiency on Hepatocarcinogenesis
Toxicol Pathol, January 1, 1985; 13(1): 36 - 49.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.